|
BKNM-R-07021253
N/A |
|
DSPE-PEG-HD37Fab′ phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021254
N/A |
|
DSPE-PEG-CD19 mAb HD37 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021252
N/A |
|
DSPE-PEG-rituximab phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021251
N/A |
|
DSPE-PEG-OX26 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021250
N/A |
|
DSPE-PEG-Anti-CD19 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021249
N/A |
|
DSPE-PEG-Anti-ErbB2 scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021248
N/A |
|
DSPE-PEG-Anti-CD20 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021247
N/A |
|
DSPE-PEG-Antinucleosome mAb 2C5 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
BK2020083104
CAS |
|
Mo2C Mxene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021246
N/A |
|
DSPE-PEG-Anti-CD44 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021244
N/A |
|
DSPE-PEG-anti-CD37 mAb phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021243
N/A |
|
DSPE-PEG-YEQDPWGVKWWY phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021242
N/A |
|
DSPE-PEG-Anti-ErbB2 scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021241
N/A |
|
DSPE-PEG-rhuMAb HER2-Fab’or scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021240
N/A |
|
DSPE-PEG-Anti-HER2 Fab’or scFv F5 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021239
N/A |
|
DSPE-PEG-Anti-ErbB2 scFv phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BKNM-R-07021237
N/A |
|
DSPE-PEG-Anti-HER2 Fab’or scFv F5 phospholipid-polyethylene glycol-tumor targeting protein
|
￥Member visible
|
|
|
BK2020082001
CAS |
|
Ta4C3 Mxene quantum dots
|
￥Member visible
|
|
|
BK2021010601
CAS |
|
Carboxylated Ti3C2 MXene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021236
N/A |
|
DSPE-PEG-ZnDPA Phospholipid-polyethylene glycol-ZnDPA
|
￥Member visible
|
|
|
BK2020010602
CAS |
|
Aminated Ti3C2 MXene quantum dots
|
￥Member visible
|
|
|
BKNM-R-07021235
N/A |
|
DSPE-PEG-Isothiocyanate Distearoylphosphatidylethanolamine-polyethylene glycol-isothiocyanate
|
￥Member visible
|
|
|
BKNM-R-07021234
N/A |
|
DSPE-PEG-Niacin Distearoylphosphatidylethanolamine-polyethylene glycol-nicotinic acid
|
￥Member visible
|
|
|
BKNM-R-07021233
N/A |
|
DSPE-PEG-Tretinoin Distearoylphosphatidylethanolamine-polyethylene glycol-retinoic acid
|
￥Member visible
|
|
|
BKNM-R-07021232
N/A |
|
DSPE-PEG-Cyclodextrin Distearoylphosphatidylethanolamine-polyethylene glycol-cyclodextrin
|
￥Member visible
|
|
|
BKNM-R-07021231
N/A |
|
DSPE-PEG-Mesylate Distearoylphosphatidylethanolamine-polyethylene glycol-mesylate
|
￥Member visible
|
|
|
BKNM-R-07021230
N/A |
|
DSPE-PEG-linoleic acid Distearoylphosphatidylethanolamine-polyethylene glycol-linoleic acid
|
￥Member visible
|
|
|
BKNM-R-07021229
N/A |
|
DSPE-PEG-PFP Distearoylphosphatidylethanolamine-polyethylene glycol-pentafluorophenol Pentafluorophenyl
|
￥Member visible
|
|
|
BKNM-R-07021228
N/A |
|
DSPE-PEG-Benzaldehyde Distearoylphosphatidylethanolamine-polyethylene glycol-benzaldehyde
|
￥Member visible
|
|
|
BKNM-R-07021227
N/A |
|
DSPE-PEG-phosphoric acid Distearoylphosphatidylethanolamine-polyethylene glycol-phosphoric acid
|
￥Member visible
|
|
|
BKNM-R-07021226
N/A |
|
DSPE-PEG-Phenyl Distearoylphosphatidylethanolamine-polyethylene glycol-phenyl
|
￥Member visible
|
|
|
BKNM-R-20021122
N/A |
|
DLPE-PEG-CHEMS Dilauroylphosphatidylethanolamine-polyethylene glycol-cholesteryl hemisuccinate
|
￥Member visible
|
